Prognostic value of complete remission status at end-of-treatment FDG-PET in R-CHOP-treated diffuse large B-cell lymphoma: systematic review and meta-analysis-Reference-Cited by-同舟云学术

Prognostic value of complete remission status at end-of-treatment FDG-PET in R-CHOP-treated diffuse large B-cell lymphoma: systematic review and meta-analysis

Published:2015-04-01 Issue:2 Volume:170 Page:185-191
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Adams Hugo J. A.¹,Nievelstein Rutger A. J.¹,Kwee Thomas C.¹

Affiliation:

1. Department of Radiology and Nuclear Medicine; University Medical Centre Utrecht; Utrecht the Netherlands

Funder

KWF Kankerbestrijding

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.13420/fullpdf

Reference24 articles.

1. Bone marrow 18F-fluoro-2-deoxy-d-glucose positron emission tomography/computed tomography cannot replace bone marrow biopsy in diffuse large B-cell lymphoma;Adams;American Journal of Hematology,2014a

2. Direct comparison of visual and quantitative bone marrow FDG-PET/CT findings with bone marrow biopsy results in diffuse large B-cell lymphoma: does bone marrow FDG-PET/CT live up to its promise?;Adams;Acta Radiologica,2014b

3. Strikingly high false positivity of surveillance FDG-PET/CT scanning among patients with diffuse large cell lymphoma in the rituximab era;Avivi;American Journal of Hematology,2013

4. Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group;Barrington;Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology,2014

5. 18F-FDG PET/CT for early response assessment in diffuse large B-cell lymphoma: poor predictive value of international harmonization project interpretation;Cashen;Journal of Nuclear Medicine: Official Publication, Society of Nuclear Medicine,2011

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Circulating Tumor DNA as a Complementary Prognostic Biomarker during CAR-T Therapy in B-Cell Non-Hodgkin Lymphomas;Cancers;2024-05-15

2. Primary gastric diffuse large B‐cell lymphoma: A multicentre retrospective study;British Journal of Haematology;2024-04-17

3. Development and validation of a novel risk stratification model and a survival rate calculator for diffuse large B-cell lymphoma in the rituximab era: a multi-institutional cohort study;Annals of Hematology;2023-10-20

4. Prognostic value of post-treatment serum soluble interleukin-2 receptor in newly diagnosed diffuse large B-cell lymphoma patients who achieved complete metabolic response following R-CHOP therapy;Scientific Reports;2023-08-22

5. Measurable residual disease after CAR T-cell therapy;Seminars in Hematology;2023-01